UNDERSTANDING ARTHRITIS

Uveitis

UNDERSTANDING ARTHRITIS

What Uveitis?

Uveitis is an autoimmune disease that causes a part of the eye to become inflamed. The immune system attacks the eyes and causes damage that can lead to vision problems. Uveitis can be caused by infections or by autoimmune diseases such as rheumatoid arthritis or psoriasis. There are different types of uveitis that are based on the part of the eye that is affected:

  • Anterior uveitis is when the front of the eye is inflamed. Symptoms can be constant or come and go, and usually last for weeks.
  • Intermediate uveitis is when the middle of the eye is inflamed. Symptoms can come and go for weeks or years.
  • Posterior uveitis is when the back of the eye is inflamed. Symptoms start gradually and last for years.

Learn More About Uveitis

Download this FREE fact sheet to get detailed information on the diagnosis and management of Uveitis!

Uveitis

Learn More

Signs and Symptoms of Uveitis?

Symptoms of uveitis can start suddenly start and stop. These symptoms may include:

  • Blurry vision
  • Painful or red eyes
  • Light sensitivity
  • Seeing floaters (such as dark spots or squiggly lines)

 

More than 100,000 people in the United States have uveitis. Anyone can have uveitis. But some people have a higher risk of having it.

  • Women are slightly more likely to have uveitis than men.
  • People between the ages of 20 and 60 – and your risk increases as you get older.

Causes of Uveitis

Researchers believe that if a family member has uveitis, you are more likely to have the disease. Many people with no family history of uveitis still develop the disease.

Your environment or lifestyle could also increase your risk.
Smoking, vitamin D deficiency, and certain infections can increase your chance of developing of uveitis.

Translate »

Connect with ANRF Today!

Stay up -to-date with the latest arthritis news, stories and info.​

Make a Donation

Make a one-time or recurring donation and know that you are making a difference by funding cutting-edge arthritis research.

Skip to content